Vol. 2 No. 2 (2010)

Artigos

• Advanced breast cancer treatment, hormonereceptor-positive with endocrine therapy versus chemotherapy: economic analysis in the Brazilian Public Healthcare System (BPHS)

  Elias Abdo Filho, Maíra Takemoto, Vanessa Teich, Fernando Quintella, Roberta Fernandes, Roberta Passos, Nelson Luiz Teich, Alessandra Silva, Mario Sergio Marques, Juvenal Mottola Júnior, Luiz Henrique Gebrim, Sergio Picinini, Milton Sakano

  46-51

  • PDF

• Buget impact analysis of endometriosis clinical treatment in the Brazilian Public Health Care System

  Rogério Machado, Roberta Passos, Vanessa Teich, Júlio César Carvalho, Marcelo Molinari, Márcio Krambek

  52-58

  • PDF (Português (Brasil))

• Pharmacoeconomics Assessment of cost-effectiveness for the treatment of Community-Acquired Pneumonia and Chronic Bronchitis Exacerbations with gemifloxacin in patients attended at the Instituto Mexicano del Seguro Social

  Guillermo Salinas-Escudero, Iris Contreras-Hernández, Joaquín Mould-Quevedo, Sergio Sanchez-García, Teresa Juarez-Cedillo, Juan Mejía-Aranguré

  59-68

  • PDF (Português (Brasil))

• Cost-effectiveness analysis of propafenone and amiodarone for atrial fibrillation initial treatment

  Camila Pepe, Roberta Fernandes, Francisco Darrieux, Dalmo Moreira, Thiago Rodrigues, Márcio Figueiredo, Leonardo Chaves

  69-76

  • PDF (Português (Brasil))

• Cost-effectiveness analysis of knee osteoarthritis treatment with sodium hyaluronate 25mg/2,5mL in the Brazilian public healthcare system

  Roberta Fernandes, Vanessa Teich, Júlio César Carvalho, Marcelo Molinari, Márcio Krambek

  77-86

  • PDF (Português (Brasil))

• Pharmacoeconomic analysis of OROS hydromorphone for the treatment of chronic cancer pain under the Brazilian public health care system perspective

  Maíra Takemoto, Roberta Roberta Arinelli Fernandes, Roberta Freitas, Fábio Guerra, Maria Lúcia Pereira, André Morais

  87-95

  • PDF (Português (Brasil))

• Cost-effectiveness of prophylaxis and treatment of venous thromboembolic disease (VTE) in patients undergoing hip surgery in Mexico

  Hector Arreola-Ornelas, Alfonso Rosado-Buzzo, Lourdes García-Mollinedo, Javier Dorantes-Aguilar, Emilio Muciño-Ortega, Joaquín Mould-Quevedo

  96-108

  • PDF (Português (Brasil))

• Are there differences between healthcare technology assessment for devices and for drugs?

  Mario Saggia

  109-110

  • PDF (Português (Brasil))